Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
A. Strezova, J. Díez-Domingo, Kamal Al Shawafi, J. Tinoco +173 more

